- Report
- May 2026
- 150 Pages
Australia
From €4476EUR$4,850USD£3,748GBP
- Report
- May 2026
- 150 Pages
Brazil
From €4476EUR$4,850USD£3,748GBP
- Report
- May 2026
- 150 Pages
India
From €4476EUR$4,850USD£3,748GBP
- Report
- May 2026
- 150 Pages
Indonesia
From €4476EUR$4,850USD£3,748GBP
- Report
- May 2026
- 150 Pages
Italy
From €4476EUR$4,850USD£3,748GBP
- Report
- May 2026
- 150 Pages
United Kingdom
From €4476EUR$4,850USD£3,748GBP
- Report
- May 2026
- 150 Pages
Canada
From €4476EUR$4,850USD£3,748GBP
- Report
- May 2026
- 150 Pages
Germany
From €4476EUR$4,850USD£3,748GBP
- Report
- May 2026
- 150 Pages
China
From €4476EUR$4,850USD£3,748GBP
- Report
- May 2026
- 150 Pages
Netherlands
From €4476EUR$4,850USD£3,748GBP
- Report
- May 2026
- 150 Pages
Japan
From €4476EUR$4,850USD£3,748GBP
- Report
- March 2026
- 210 Pages
Germany
From €4476EUR$4,850USD£3,748GBP
- Report
- March 2026
- 176 Pages
China
From €4476EUR$4,850USD£3,748GBP
- Report
- March 2026
- 150 Pages
Canada
From €4476EUR$4,850USD£3,748GBP
- Report
- March 2026
- 244 Pages
India
From €4476EUR$4,850USD£3,748GBP
- Report
- October 2025
- 150 Pages
Global
From €4476EUR$4,850USD£3,748GBP
- Report
- August 2025
- 150 Pages
Global
From €4476EUR$4,850USD£3,748GBP
- Report
- May 2025
- 150 Pages
Global
From €4476EUR$4,850USD£3,748GBP
- Report
- December 2024
- 150 Pages
Global
From €4476EUR$4,850USD£3,748GBP
- Report
- January 2024
- 150 Pages
Global
From €4476EUR$4,850USD£3,748GBP

The Antifungal Drug market is a subset of the larger Infectious Diseases Drugs market. Antifungal drugs are used to treat fungal infections, which can range from mild to life-threatening. These drugs work by either killing the fungus or preventing its growth. Common antifungal drugs include azoles, polyenes, and echinocandins. Azoles are the most commonly prescribed antifungal drugs, and are used to treat a wide range of fungal infections. Polyenes are used to treat more serious fungal infections, while echinocandins are used to treat severe fungal infections.
The Antifungal Drug market is highly competitive, with many companies offering a variety of products. Some of the major players in the market include Pfizer, Merck, Novartis, GlaxoSmithKline, and AstraZeneca. Other companies in the market include Bayer, Sanofi, Allergan, and Johnson & Johnson. Show Less Read more